跳至主要内容
临床试验/ACTRN12620000553976
ACTRN12620000553976尚未招募未知

Prevention of harmfull effect of hyperoxia with new monitorization method : ORI (oxygen reserve index )

Marmara University Medical Faculty0 个研究点目标入组 20 人开始时间: 2020年5月11日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 Months 至 24 Months(—)
性别
All

入选标准

  • 20 children who will undergo craniocinocytosis surgery, ASA I-II, 2-24 months of age and written informed consent from their families or legal officers will be included in the study.

排除标准

  • Children with congenital or traumatic extremity pathology, with a history of allergy to the sensor material and body weight of less than 3 kg, patients with rectal abnormalities, thus contraindicated for rectal temperature probe placement, patients undergoing emergency surgery, or known heart failure or hypertension children with cardiac or vascular disease will be excluded from the study.

研究者

发起方
Marmara University Medical Faculty

相似试验